ESM-I (n = 33) | Pseudo-intervention (n = 35) | Control (n = 33) | Regression coefficients; B (95% confidence interval)a | ||
---|---|---|---|---|---|
ESM-I vs Control | ESM-I vs Pseudo-intervention | ||||
HDRS (at 32 weeks) | |||||
HDRS scorea | 10.8 (7.1) | 13 (7.12) | 15.3 (8.3) | −3.1 (−6.2; 0.01) | −1.13 (−4.18; 1.92) |
Improvement since baseline | 2.7 (6.1) | 2.1 (5.9) | 0.24 (7.5) | 3.1 (−0.01; 6.2) | 1.13 (−1.92; 4.18) |
Symptomatic remissionb | 11 (33.3) | 9 (25.7) | 6 (18.2) | OR = 2.65 (0.79; 8.9) | OR = 1.84 (0.59; 5.7) |
QALYs (over 32 weeks) | |||||
EQ-5D, UK tariff | 0.45 (0.17) | 0.38 (0.18) | 0.32 (0.18) | 0.08 (0.02; 0.10)* | 0.04 (−0.02; 0.10) |